Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ruiz, Anna ^a   Llort, Gemma ^b   Yagüe, Carmen ^b   Baena, Neus ^a   Viñas, Marina ^a   Torra, Montse ^a   Brunet, Anna ^c   Seguí, Miquel A ^c   Saigí, Eugeni ^c   Guitart, Miriam ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Unidad de Consejo Genético Institut Oncològic Del Vallès Corporació Sanitària Parc Taulí   (Spain)

^c Hospital Universitari Parc Taulí   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

AMPLICON; ANALYTICAL EQUIPMENT; ARTICLE; BRCA HP KIT; BRCA MASTR KIT; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; EXON; FALSE POSITIVE RESULT; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDEL MUTATION; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PYROSEQUENCING; SENSITIVITY AND SPECIFICITY; BREAST TUMOR; GENETICS; HIGH THROUGHPUT SEQUENCING; MUTATION; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PROCEDURES;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84904108871     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/542541     Document Type: Article

References (23)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P. K., Norris F. H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J. C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A., Skolnick M. H., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994 266 5182 66 71 10.1126/science.7545954 2-s2.0-0028113345 (Pubitemid 24345325)
2. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Michlem G., Barfoot R., Hamoudi R., Patel S., Rice C., Biggs P., Hashim Y., Smith A., Connor F., Arason A., Identification of the breast cancer susceptibility gene BRCA2. Nature 1995 378 6559 789 792 2-s2.0-0030029728 (Pubitemid 26004412)
3. Antoniou A., Pharoah P. D. P., Narod S., Risch H. A., Eyfjord J. E., Hopper J. L., Loman N., Olsson H., Johannsson O., Borg Å., Pasini B., Radice P., Manoukian S., Eccles D. M., Tang N., Olah E., Anton-Culver H., Warner E., Lubinski J., Gronwald J., Gorski B., Tulinius H., Thorlacius S., Eerola H., Nevanlinna H., Syrjäkoski K., Kallioniemi O.-., Thompson D., Evans C., Peto J., Lalloo F., Evans D. G., Easton D. F., Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. The American Journal of Human Genetics 2003 72 5 1117 1130 10.1086/375033 2-s2.0-0038744296 (Pubitemid 36530000)
4. King M., Marks J. H., Mandell J. B., Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003 302 5645 643 646 10.1126/science.1088759 2-s2.0-0142178215 (Pubitemid 37310920)
5. Pruthi S., Gostout B. S., Lindor N. M., Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer. Mayo Clinic Proceedings 2010 85 12 1111 1120 10.4065/mcp.2010.0414 2-s2.0-78650078754
6. Paradiso A., Formenti S., Hereditary breast cancer: clinical features and risk reduction strategies. Annals of Oncology 2011 22 1 supplement 1 i31 i36 10.1093/annonc/mdq663 2-s2.0-79551643321
7. Gerhardus A., Schleberger H., Schlegelberger B., Gadzicki D., Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. European Journal of Human Genetics 2007 15 6 619 627 10.1038/sj.ejhg.5201806 2-s2.0-34249717959 (Pubitemid 46825051)
8. Voelkerding K. V., Dames S. A., Durtschi J. D., Next-generation sequencing: from basic research to diagnostics. Clinical Chemistry 2009 55 4 641 658 10.1373/clinchem.2008.112789 2-s2.0-64149123778
9. Bentley D. R., Whole-genome re-sequencing. Current Opinion in Genetics and Development 2006 16 6 545 552 10.1016/j.gde.2006.10.009 2-s2.0-33750953227 (Pubitemid 44738530)
10. Mamanova L., Coffey A. J., Scott C. E., Kozarewa I., Turner E. H., Kumar A., Howard E., Shendure J., Turner D. J., Target-enrichment strategies for next-generation sequencing. Nature Methods 2010 7 2 111 118 10.1038/nmeth.1419 2-s2.0-77449121614
11. Puente X. S., Pinyol M., Quesada V., Conde L., Ordóñez G. R., Villamor N., Escaramis G., Jares P., Beá S., González- Díaz M., Bassaganyas L., Baumann T., Juan M., López-Guerra M., Colomer D., Tubío J. M. C., López C., Navarro A., Tornador C., Aymerich M., Rozman M., Hernández J. M., Puente D. A., Freije J. M. P., Velasco G., Gutiérrez-Fernández A., Costa D., Carrio A., Guijarro S., Enjuanes A., Hernndez L., Yage J., Nicols P., Romeo-Casabona C. M., Himmelbauer H., Castillo E., Dohm J. C., De Sanjos S., Piris M. A., De Alava E., Miguel J. S., Royo R., Gelpi J. L., Torrents D., Orozco M., Pisano D. G., Valencia A., Guigi R., Bayes M., Heath S., Gut M., Klatt P., Marshall J., Raine K., Stebbings L. A., Futreal P. A., Stratton M. R., Campbell P. J., Gut I., Lopez-Guillermo A., Estivill X., Montserrat E., López-Otín C., Campo E., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011 475 7354 101 105 10.1038/nature10113 2-s2.0-79960036578
12. Choi M., Scholl U. I., Ji W., Liu T., Tikhonova I. R., Zumbo P., Nayir A., Bakkalolu A., Özen S., Sanjad S., Nelson-Williams C., Farhi A., Mane S., Lifton R. P., Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America 2009 106 45 19096 19101 10.1073/pnas.0910672106 2-s2.0-73149123343
13. Morgan J. E., Carr I. M., Sheridan E., Chu C. E., Hayward B., Camm N., Lindsay H. A., Mattocks C. J., Markham A. F., Bonthron D. T., Taylor G. R., Genetic diagnosis of familial breast cancer using clonal sequencing. Human Mutation 2010 31 4 484 491 10.1002/humu.21216 2-s2.0-77955059918
14. Walsh T., Casadei S., Lee M. K., Pennil C. C., Nord A. S., Thornton A. M., Roeb W., Agnew K. J., Stray S. M., Wickramanayake A., Norquist B., Pennington K. P., Garcia R. L., King M., Swisher E. M., Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proceedings of the National Academy of Sciences of the United States of America 2011 108 44 18032 18037 10.1073/pnas.1115052108 2-s2.0-81055126264
15. de Leeneer K., Hellemans J., de Schrijver J., Baetens M., Poppe B., Van Criekinge W., De Paepe A., Coucke P., Claes K., Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Human Mutation 2011 32 3 335 344 10.1002/humu.21428 2-s2.0-79951805438
16. Michils G., Hollants S., Dehaspe L., Van Houdt J., Bidet Y., Uhrhammer N., Bignon Y., Vermeesch J. R., Cuppens H., Matthijs G., Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing. Journal of Molecular Diagnostics 2012 14 6 623 630 10.1016/j.jmoldx.2012.05.006 2-s2.0-84867404095
17. Hernan I., Borràs E., de Sousa Dias M., Gamundi M. J., Maé B., Llort G., Agndez J. A. G., Blanca M., Carballo M., Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing. Journal of Molecular Diagnostics 2012 14 3 286 293 10.1016/j.jmoldx.2012.01.013 2-s2.0-84859574256
18. Feliubadaló L., Lopez-Doriga A., Castellsagué E., Del Valle J., Menéndez M., Tornero E., Montes E., Cuesta R., Gómez C., Campos O., Pineda M., González S., Moreno V., Brunet J., Blanco I., Serra E., Capellá G., Lázaro C., Next-generation sequencing meets genetic diagnostics: Development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. European Journal of Human Genetics 2013 21 8 864 870 10.1038/ejhg.2012.270 2-s2.0-84880922809
19. Tavtigian S. V., Greenblatt M. S., Goldgar D. E., Boffetta P., Assessing pathogenicity: overview of results from the IARC unclassified genetic variants working group. Human Mutation 2008 29 11 1261 1264 10.1002/humu.20903 2-s2.0-55549111626
20. de Leeneer K., de Schrijver J., Clement L., Baetens M., Lefever S., de Keulenaer S., van Criekinge W., Deforce D., van Nieuwerburgh F., Bekaert S., Pattyn F., de Wilde B., Coucke P., Vandesompele J., Claes K., Hellemans J., Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics. PLoS ONE 2011 6 9 e25531 10.1371/journal.pone.0025531 2-s2.0-80053590678
21. Huse S. M., Huber J. A., Morrison H. G., Sogin M. L., Welch D. M., Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biology 2007 8 7, article R143 10.1186/gb-2007-8-7-r143 2-s2.0-34948842866 (Pubitemid 351903194)
22. Diez O., Gutiérrez-Enríquez S., Balmaña J., Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing. Familial Cancer 2010 9 2 187 191 10.1007/s10689-009-9301-5
23. Carvalho M., Pino M. A., Karchin R., Beddor J., Godinho-Netto M., Mesquita R. D., Rodarte R. S., Vaz D. C., Monteiro V. A., Manoukian S., Colombo M., Ripamonti C. B., Rosenquist R., Suthers G., Borg A., Radice P., Grist S. A., Monteiro A. N. A., Billack B., Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1. Mutation Research 2009 660 1-2 1 11 10.1016/j.mrfmmm.2008.09.017 2-s2.0-58249090764